Martin Shkreli (/ˈskrɛli/; born April 1, 1983) is an American entrepreneur and financial and pharmaceutical executive. He is co-founder of the hedge fund MSMB Capital Management, co-founder and former chief executive officer (CEO) of the biotechnology firm Retrophin LLC, and founder and former CEO of Turing Pharmaceuticals AG. In September 2015, Shkreli received widespread criticism when Turing obtained the manufacturing license for the antiparasitic drug Daraprim and raised its price by 5,556 percent (from US$13.50 to US$750 per tablet).
On December 17, 2015, Shkreli was arrested by the FBI on charges of securities fraud and released on bail. He resigned as CEO of Turing Pharmaceuticals and was replaced by the company’s board chairman, Ron Tilles.
Starting in 2008, Shkreli served as chairman of the board of directors of the National Albanian American Council, a nonprofit organization that advocates for Albanians and promotes peace and economic development for human rights in the Balkans. He continued in this role as of 2014
Shkreli was revealed as the winner of an auction for the Wu-Tang Clan album Once Upon a Time in Shaolin after the single copy of the album was sold via Paddle8 on November 24, 2015, for US$2 million to what was reported to be a “private American collector.” On December 9, 2015, Bloomberg Businessweek identified Shkreli as the purchaser.
https://www.independent.co.ukMartin Shkreli resigns as CEO of Turi
https://www.forbes.comMartin Shkreli: ‘I Would’ve Raised Pric
https://abcnews.go.comTuring Pharmaceuticals CEO Martin
https://guardianlv.comMartin Shkreli Arrested for Securities
https://www.bloomberg.comPharma’s Bad Boy Exec Paid $2 Milli
https://www.businessinsider.comWhy we need Martin Shkreli – Busines
https://www.attn.comWhy Martin Shkreli Might Actually Lea